Bjoern Papke

Also affiliated with Heidelberg University, Humboldt-Universität zu Berlin

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Silencing of oncogenic KRAS by mutant-selective small interfering RNA”.

Silencing of oncogenic KRAS by mutant-selective small interfering RNA

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.08.331835

N/A

0DataRank · unranked

2 citations

Salma H. Azam, Anne Y. Feng, Amanda E.D. Van Swearingen, Christina Gutierrez-Ford, Pradeep S. Pallan +5 more

Defining the KRAS-regulated kinome in KRAS-mutant pancreatic cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.27.441678

N/A

0DataRank · unranked

0 citations

Jennifer E. Klomp, Kayla R. Snare, Devon R. Blake, Priya S. Hibshman, Zane D. Kaiser +13 more

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS- Mutant Pancreatic Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-0391

N/A

0DataRank · unranked

163 citations

Andrew M. Waters, Jennifer E. Klomp, Sehrish Javaid, Kirsten L. Bryant, Clint A. Stalnecker +19 more

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

UNC Libraries(2024)10.17615/2caa-2659

N/A

0DataRank · unranked

24 citations

Daniel Zeitouni, Clint A. Stalnecker, Haoqiang Ying, Erik S. Knudsen, Guofang Zhang +26 more

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.

UNC Libraries(2024)10.17615/s0p7-tg86

N/A

0DataRank · unranked

12 citations

Jennifer E. Klomp, Bjoern Papke, Craig M. Goodwin, Andrew P. Beelen, Clint A. Stalnecker +19 more